Submitted by Anonymous (not verified) on 30 November 2023 - 16:39
Human medicines European public assessment report (EPAR): Xelevia, sitagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 21/03/2007, Revision: 39, Status: Authorised
Source: